Valuation: Krka, d. d.

Market Cap 7.9B 8.99B 7.36B 6.76B 12.69B 862B 12.85B 87.44B 34.15B 426B 33.74B 33.02B 1,471B P/E 2026 *
19.1x
P/E 2027 * 18.1x
Enterprise Value 7.23B 8.23B 6.73B 6.18B 11.61B 789B 11.76B 80.02B 31.25B 390B 30.88B 30.22B 1,346B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.13x
Free-Float
74.74%
Yield 2026 *
3.48%
Yield 2027 * 3.84%
1 day-0.37%
Current month+6.79%
1 month+4.09%
3 months+9.63%
6 months+19.96%
Current year+31.77%
1 week 258
Extreme 258
269.5
1 month 249.5
Extreme 249.5
270
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Director of Finance/CFO - 2025-12-31
Chief Tech/Sci/R&D Officer - 2023-02-28
Director TitleAgeSince
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 73 2009-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%0.00%+37.53%+136.73% 9.01B
+1.68%+0.88%+16.17%+73.90% 48.36B
-0.04%+2.21%+61.55%+110.23% 35.8B
-0.09%-2.23%-8.03%+20.31% 11.83B
-0.05%-3.55%+13.50%+70.62% 11.48B
-0.47%+1.27%+46.68%-6.87% 6.99B
+0.95%-1.59%+12.78%+32.81% 6.7B
+0.18%-1.94%+2.36%+167.04% 6.42B
+3.51%-10.69%-31.55%+1.09% 5.3B
+0.49%-2.39%+21.61%+118.10% 4.37B
Average +0.58%-1.23%+17.26%+72.40% 14.63B
Weighted average by Cap. +0.69%-0.18%+25.56%+79.10%

Financials

2026 *2027 *
Net sales 2.17B 2.46B 2.02B 1.85B 3.48B 236B 3.52B 23.97B 9.36B 117B 9.25B 9.05B 403B 2.3B 2.61B 2.14B 1.97B 3.69B 251B 3.74B 25.43B 9.93B 124B 9.82B 9.6B 428B
Net income 420M 478M 391M 359M 674M 45.81B 683M 4.65B 1.81B 22.62B 1.79B 1.75B 78.19B 445M 507M 415M 381M 715M 48.6B 725M 4.93B 1.93B 24B 1.9B 1.86B 82.94B
Net Debt -670M -762M -624M -573M -1.08B -73.09B -1.09B -7.41B -2.9B -36.09B -2.86B -2.8B -125B -708M -805M -659M -605M -1.14B -77.21B -1.15B -7.83B -3.06B -38.12B -3.02B -2.96B -132B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
26-07-27 €261.00 -0.19% 4,270
26-07-24 €261.50 +0.19% 7,068
26-07-23 €261.00 +0.38% 5,093
26-07-22 €260.00 +0.39% 5,111
26-07-21 €259.00 -3.18% 12,756
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
261.00EUR
Average target price
242.65EUR
Spread / Average Target
-7.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock